4.8 Article

Accelerated lysine metabolism conveys kidney protection in salt-sensitive hypertension

Journal

NATURE COMMUNICATIONS
Volume 13, Issue 1, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41467-022-31670-0

Keywords

-

Funding

  1. National Institutes of Health [HL135749, CA231991, DK126720, UL1TR001450/SCTR 2214]
  2. SC SmartState Centers of Excellence
  3. Spanish Ministry of Science and Innovation - State Research Agency (AEI) [PID2019-106277RA-I00]
  4. Department of Veteran Affairs [I01 BX004024]
  5. DFG [Ri2811-1/2, Ri2811-2]
  6. Novo Nordisk Foundation Young Investigator Grant
  7. Aarhus University Forskening Fonden (AUFF)
  8. European Union [754513]
  9. Aarhus University Research Foundation (AIAS-COFUNDII fellowship)

Ask authors/readers for more resources

This study used isotope-guided metabolomics to investigate the metabolism of lysine in hypertension and found that lysine administration can protect the kidneys from hypertensive kidney damage.
Kidney metabolism in disease is important but not well understood. Here, using isotope-guided metabolomics, the authors show that lysine's metabolic activity conveys kidney protection in hypertension through accelerated metabolism and physiological effects on tubular function. Hypertension and kidney disease have been repeatedly associated with genomic variants and alterations of lysine metabolism. Here, we combined stable isotope labeling with untargeted metabolomics to investigate lysine's metabolic fate in vivo. Dietary C-13(6) labeled lysine was tracked to lysine metabolites across various organs. Globally, lysine reacts rapidly with molecules of the central carbon metabolism, but incorporates slowly into proteins and acylcarnitines. Lysine metabolism is accelerated in a rat model of hypertension and kidney damage, chiefly through N-alpha-mediated degradation. Lysine administration diminished development of hypertension and kidney injury. Protective mechanisms include diuresis, further acceleration of lysine conjugate formation, and inhibition of tubular albumin uptake. Lysine also conjugates with malonyl-CoA to form a novel metabolite N epsilon-malonyl-lysine to deplete malonyl-CoA from fatty acid synthesis. Through conjugate formation and excretion as fructoselysine, saccharopine, and N epsilon-acetyllysine, lysine lead to depletion of central carbon metabolites from the organism and kidney. Consistently, lysine administration to patients at risk for hypertension and kidney disease inhibited tubular albumin uptake, increased lysine conjugate formation, and reduced tricarboxylic acid (TCA) cycle metabolites, compared to kidney-healthy volunteers. In conclusion, lysine isotope tracing mapped an accelerated metabolism in hypertension, and lysine administration could protect kidneys in hypertensive kidney disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available